A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma

J Biomol Screen. 2007 Mar;12(2):240-7. doi: 10.1177/1087057106297566. Epub 2007 Jan 26.


The authors describe a homogeneous, sensitive, and rapid bead-based sandwich immunoassay with a broad analytical range for quantifying insulin in human plasma. The assay was performed as a 2-step reaction by incubating the sample with a mixture of biotinylated anti-insulin antibody and beads covalently coated with anti-insulin antibody for 1 h. This was followed by incubation with beads covalently coated with streptavidin for 30 min. After the incubation steps, light generated from a chemiluminescent reaction within the beads was quantitated. The assay was run in 384-well plates with a sample volume of 5 microL. The analytical range extended from 1 to 10,000 pM. Intra-assay precision (% coefficient of variation) ranged from 1.9% to 3.8% for various insulin concentrations. Interassay precision ranged from 4.6% to 7.3%. Assay detection limit was 0.3 pM. There was no interference from moderate hemolysis (with hemoglobin up to 375 mg/dL), bilirubin (up to at least 50 mg/dL), triglyceride (up to at least 1000 mg/dL), biotin (up to at least 7.7 ng/mL), or ascorbic acid (up to 100 mg/dL). However, gross hemolysis did affect the assay. Comparable results were obtained for plasma (ethylenediamine tetra-acetic acid, citrate, and heparin treated) and serum. The correlation with enzyme-linked immunosorbent assay (ELISA) was good (y = 1.25x + 1.19, R(2) = 0.98). This method is convenient and represents an alternative to ELISA.

Publication types

  • Comparative Study

MeSH terms

  • Calibration
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Hypoglycemic Agents / blood*
  • Hypoglycemic Agents / immunology
  • Hypoglycemic Agents / pharmacology
  • Immunoassay / methods*
  • Insulin / blood*
  • Insulin / immunology
  • Insulin / pharmacology
  • Kinetics
  • Luminescent Measurements
  • Reproducibility of Results
  • Sensitivity and Specificity


  • Hypoglycemic Agents
  • Insulin